LXR antagonists induce ABCD2 expression

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 2, 2014, Pages 259-266

  Gondcaille, Catherine ^a   Genin, Emmanuelle C ^a   Lopez, Tatiana E ^a   Dias, Alexandre M M ^a   Geillon, Flore ^a   Andreoletti, Pierre ^a   Cherkaoui Malki, Mustapha ^a   Nury, Thomas ^a   Lizard, Gérard ^a   Weinhofer, Isabelle ^b   Berger, Johannes ^b   Kase, Eili T ^c   Trompier, Doriane ^a   Savary, Stéphane ^a  

^a Faculté des Sciences Gabriel   (France)

^b Medical University of Vienna   (Austria)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

ABCD2; Hydroxycholesterol; LXR; Very long chain fatty acid; X ALD

Indexed keywords

22 HYDROXYCHOLESTEROL; ABC TRANSPORTER; ABC TRANSPORTER D2; ABC TRANSPORTER D3; BETA CATENIN; CARNITINE PALMITOYLTRANSFERASE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3;

ADRENOLEUKODYSTROPHY; ALTERNATIVE MEDICINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DYSLIPIDEMIA; FATTY ACID ANALYSIS; FATTY ACID OXIDATION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKIN FIBROBLAST; UPREGULATION;

RATTUS;

ADRENOLEUKODYSTROPHY; ATP-BINDING CASSETTE TRANSPORTERS; FATTY ACIDS; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; HYDROXYCHOLESTEROLS; ORPHAN NUCLEAR RECEPTORS; OXIDATIVE STRESS;

EID: 84890513139     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2013.11.003     Document Type: Article

References (54)

1. D. Trompier, and S. Savary X-linked Adrenoleukodystrophy 2013 Morgan & Claypool Life Sciences
2. L. Bezman, A.B. Moser, G.V. Raymond, P. Rinaldo, P.A. Watkins, K.D. Smith, N.E. Kass, and H.W. Moser Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening Ann. Neurol. 49 2001 512 517
3. J. Mosser, A.M. Douar, C.O. Sarde, P. Kioschis, R. Feil, H. Moser, A.M. Poustka, J.L. Mandel, and P. Aubourg Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters Nature 361 1993 726 730
4. C. Wiesinger, M. Kunze, G. Regelsberger, S. Forss-Petter, and J. Berger Impaired very long-chain Acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction J. Biol. Chem. 288 2013 19269 19279
5. G. Lombard-Platet, S. Savary, C.O. Sarde, J.L. Mandel, and G. Chimini A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern Proc. Natl. Acad. Sci. U. S. A. 93 1996 1265 1269
6. A. Holzinger, S. Kammerer, J. Berger, and A.A. Roscher cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDRP), a peroxisomal ABC transporter Biochem. Biophys. Res. Commun. 239 1997 261 264
7. K. Kamijo, S. Taketani, S. Yokota, T. Osumi, and T. Hashimoto The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily J. Biol. Chem. 265 1990 4534 4540
8. L.T. Braiterman, S. Zheng, P.A. Watkins, M.T. Geraghty, G. Johnson, M.C. McGuinness, A.B. Moser, and K.D. Smith Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins Hum. Mol. Genet. 7 1998 239 247
9. E. Flavigny, A. Sanhaj, P. Aubourg, and N. Cartier Retroviral-mediated adrenoleukodystrophy-related gene transfer corrects very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts: implications for therapy FEBS Lett. 448 1999 261 264
10. S. Kemp, H.M. Wei, J.F. Lu, L.T. Braiterman, M.C. McGuinness, A.B. Moser, P.A. Watkins, and K.D. Smith Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy Nat. Med. 4 1998 1261 1268
11. A. Netik, S. Forss-Petter, A. Holzinger, B. Molzer, G. Unterrainer, and J. Berger Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy Hum. Mol. Genet. 8 1999 907 913
12. A. Pujol, I. Ferrer, C. Camps, E. Metzger, C. Hindelang, N. Callizot, M. Ruiz, T. Pampols, M. Giros, and J.L. Mandel Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy Hum. Mol. Genet. 13 2004 2997 3006
13. C.W. van Roermund, W.F. Visser, L. Ijlst, H.R. Waterham, and R.J. Wanders Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid beta-oxidation Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1811 2010 148 152
14. S. Fourcade, M. Ruiz, C. Camps, A. Schluter, S.M. Houten, P.A. Mooyer, T. Pampols, G. Dacremont, R.J. Wanders, M. Giros, and A. Pujol A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis Am. J. Physiol. Endocrinol. Metab. 296 2009 E211 E221
15. E.C. Genin, F. Geillon, C. Gondcaille, A. Athias, P. Gambert, D. Trompier, and S. Savary Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2) J. Biol. Chem. 286 2011 8075 8085
16. J. Liu, N.S. Sabeva, S. Bhatnagar, X.A. Li, A. Pujol, and G.A. Graf ABCD2 is abundant in adipose tissue and opposes the accumulation of dietary erucic acid (C22:1) in fat J. Lipid Res. 51 2010 162 168
17. I. Weinhofer, S. Forss-Petter, M. Zigman, and J. Berger Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy Hum. Mol. Genet. 11 2002 2701 2708
18. S. Fourcade, S. Savary, S. Albet, D. Gauthe, C. Gondcaille, T. Pineau, J. Bellenger, M. Bentejac, A. Holzinger, J. Berger, and M. Bugaut Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha Eur. J. Biochem. 268 2001 3490 3500
19. S. Fourcade, S. Savary, C. Gondcaille, J. Berger, A. Netik, F. Cadepond, M. El Etr, B. Molzer, and M. Bugaut Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2) Mol. Pharmacol. 63 2003 1296 1303
20. E.C. Genin, C. Gondcaille, D. Trompier, and S. Savary Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics J. Steroid Biochem. Mol. Biol. 116 2009 37 43
21. I. Weinhofer, M. Kunze, H. Rampler, S. Forss-Petter, J. Samarut, M. Plateroti, and J. Berger Distinct modulatory roles for thyroid hormone receptors TRalpha and TRbeta in SREBP1-activated ABCD2 expression Eur. J. Cell Biol. 87 2008 933 945
22. F. Gueugnon, C. Gondcaille, S. Leclercq, J. Bellenger, S. Bellenger, M. Narce, T. Pineau, F. Bonnetain, and S. Savary Dehydroepiandrosterone up-regulates the adrenoleukodystrophy-related gene (ABCD2) independently of PPARalpha in rodents Biochimie 89 2007 1312 1321
23. S. Leclercq, J. Skrzypski, A. Courvoisier, C. Gondcaille, F. Bonnetain, A. Andre, J.M. Chardigny, S. Bellenger, J. Bellenger, M. Narce, and S. Savary Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters Biochimie 90 2008 1602 1607
24. C. Gondcaille, M. Depreter, S. Fourcade, M.R. Lecca, S. Leclercq, P.G. Martin, T. Pineau, F. Cadepond, M. Eletr, N. Bertrand, A. Beley, S. Duclos, D. De Craemer, F. Roels, S. Savary, and M. Bugaut Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator J. Cell Biol. 169 2005 93 104
25. M. Bugaut, S. Fourcade, C. Gondcaille, F. Gueugnon, M. Depreter, F. Roels, A. Netik, J. Berger, P. Martin, T. Pineau, F. Cadepond, M. El Etr, and S. Savary Pharmacological induction of redundant genes for a therapy of X-ALD: phenylbutyrate and other compounds Adv. Exp. Med. Biol. 544 2003 281 291
26. S. Fourcade, M. Ruiz, C. Guilera, E. Hahnen, L. Brichta, A. Naudi, M. Portero-Otin, G. Dacremont, N. Cartier, R. Wanders, S. Kemp, J.L. Mandel, B. Wirth, R. Pamplona, P. Aubourg, and A. Pujol Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy Hum. Mol. Genet. 19 2010 2005 2014
27. B.A. Janowski, P.J. Willy, T.R. Devi, J.R. Falck, and D.J. Mangelsdorf An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha Nature 383 1996 728 731
28. I. Weinhofer, M. Kunze, H. Rampler, A.L. Bookout, S. Forss-Petter, and J. Berger Liver X receptor alpha interferes with SREBP1c-mediated Abcd2 expression. Novel cross-talk in gene regulation J. Biol. Chem. 280 2005 41243 41251
29. C.Y. Park, H.S. Kim, J. Jang, H. Lee, J.S. Lee, J.E. Yoo, D.R. Lee, and D.W. Kim ABCD2 is a direct target of beta-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapy PLoS ONE 8 2013 e56242
30. G. Shackleford, J. Makoukji, J. Grenier, P. Liere, D. Meffre, and C. Massaad Differential regulation of Wnt/beta-catenin signaling by Liver X receptors in Schwann cells and oligodendrocytes Biochem. Pharmacol. 86 2013 106 114
31. J. Makoukji, G. Shackleford, D. Meffre, J. Grenier, P. Liere, J.M. Lobaccaro, M. Schumacher, and C. Massaad Interplay between LXR and Wnt/beta-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols J. Neurosci. 31 2011 9620 9629
32. W.J. Zuercher, R.G. Buckholz, N. Campobasso, J.L. Collins, C.M. Galardi, R.T. Gampe, S.M. Hyatt, S.L. Merrihew, J.T. Moore, J.A. Oplinger, P.R. Reid, P.K. Spearing, T.B. Stanley, E.L. Stewart, and T.M. Willson Discovery of tertiary sulfonamides as potent Liver X receptor antagonists J. Med. Chem. 53 2010 3412 3416
33. E.T. Kase, G.H. Thoresen, S. Westerlund, K. Hojlund, A.C. Rustan, and M. Gaster Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals Diabetologia 50 2007 2171 2180
34. E.T. Kase, N. Nikolic, N. Pettersen Hessvik, A.K. Fjeldheim, J. Jensen, G.H. Thoresen, and A.C. Rustan Dietary supplementation with 22-S- hydroxycholesterol to rats reduces body weight gain and the accumulation of liver triacylglycerol Lipids 47 2012 483 493
35. M. Baarine, P. Andreoletti, A. Athias, T. Nury, A. Zarrouk, K. Ragot, A. Vejux, J.M. Riedinger, Z. Kattan, G. Bessede, D. Trompier, S. Savary, M. Cherkaoui-Malki, and G. Lizard Evidence of oxidative stress in very long chain fatty acid - treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins Neuroscience 213 2012 1 18
36. C.R. Vargas, M. Wajner, L.R. Sirtori, L. Goulart, M. Chiochetta, D. Coelho, A. Latini, S. Llesuy, A. Bello Klein, R. Giugliani, M. Deon, and C.F. Mello Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy Biochim. Biophys. Acta 1688 2004 26 32
37. S. Fourcade, J. Lopez-Erauskin, J. Galino, C. Duval, A. Naudi, M. Jove, S. Kemp, F. Villarroya, I. Ferrer, R. Pamplona, M. Portero-Otin, and A. Pujol Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy Hum. Mol. Genet. 17 2008 1762 1773
38. T. Hu, P. Foxworthy, A. Siesky, J.V. Ficorilli, H. Gao, S. Li, M. Christe, T. Ryan, G. Cao, P. Eacho, M.D. Michael, and L.F. Michael Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha Endocrinology 146 2005 5380 5387
39. X. Zhang, J. Liu, W. Su, J. Wu, C. Wang, X. Kong, J.A. Gustafsson, J. Ding, X. Ma, and Y. Guan Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRalpha-SREBP1c-dependent mechanism J. Diabetes 2013 10.1111/1753-0407.12081
40. G.Z. Tao, N. Lehwald, K.Y. Jang, J. Baek, B. Xu, M.B. Omary, and K.G. Sylvester Wnt/beta-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3 J. Biol. Chem. 288 2013 17214 17224
41. M.A. Christoffolete, M. Doleschall, P. Egri, Z. Liposits, A.M. Zavacki, A.C. Bianco, and B. Gereben Regulation of thyroid hormone activation via the liver X-receptor/retinoid X-receptor pathway J. Endocrinol. 205 2010 179 186
42. K. Kawai, S. Sasaki, H. Morita, T. Ito, S. Suzuki, H. Misawa, and H. Nakamura Unliganded thyroid hormone receptor-beta1 represses liver X receptor alpha/oxysterol-dependent transactivation Endocrinology 145 2004 5515 5524
43. K. Hashimoto, R.N. Cohen, M. Yamada, K.R. Markan, T. Monden, T. Satoh, M. Mori, and F.E. Wondisford Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model J. Biol. Chem. 281 2006 295 302
44. C. Halleskog, J. Mulder, J. Dahlstrom, K. Mackie, T. Hortobagyi, H. Tanila, L. Kumar Puli, K. Farber, T. Harkany, and G. Schulte WNT signaling in activated microglia is proinflammatory Glia 59 2011 119 131
45. K. Nelissen, M. Mulder, I. Smets, S. Timmermans, K. Smeets, M. Ameloot, and J.J. Hendriks Liver X receptors regulate cholesterol homeostasis in oligodendrocytes J. Neurosci. Res. 90 2012 60 71
46. S.M. Ulven, K.T. Dalen, J.A. Gustafsson, and H.I. Nebb LXR is crucial in lipid metabolism Prostaglandins Leukot. Essent. Fat. Acids 73 2005 59 63
47. N. Zelcer, and P. Tontonoz Liver X receptors as integrators of metabolic and inflammatory signaling J. Clin. Invest. 116 2006 607 614
48. C.L. Cummins, D.H. Volle, Y. Zhang, J.G. McDonald, B. Sion, A.M. Lefrancois-Martinez, F. Caira, G. Veyssiere, D.J. Mangelsdorf, and J.M. Lobaccaro Liver X receptors regulate adrenal cholesterol balance J. Clin. Invest. 116 2006 1902 1912
49. K.D. Whitney, M.A. Watson, J.L. Collins, W.G. Benson, T.M. Stone, M.J. Numerick, T.K. Tippin, J.G. Wilson, D.A. Winegar, and S.A. Kliewer Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system Mol. Endocrinol. 16 2002 1378 1385
50. L. Wang, G.U. Schuster, K. Hultenby, Q. Zhang, S. Andersson, and J.A. Gustafsson Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration Proc. Natl. Acad. Sci. U. S. A. 99 2002 13878 13883
51. I. Bjorkhem, and S. Meaney Brain cholesterol: long secret life behind a barrier Arterioscler. Thromb. Vasc. Biol. 24 2004 806 815
52. A. Aoyama, K. Endo-Umeda, K. Kishida, K. Ohgane, T. Noguchi-Yachide, H. Aoyama, M. Ishikawa, H. Miyachi, M. Makishima, and Y. Hashimoto Design, synthesis, and biological evaluation of novel transrepression-selective liver X receptor (LXR) ligands with 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b, e]azepin-6-one skeleton J. Med. Chem. 55 2012 7360 7377
53. T. Noguchi-Yachide, A. Aoyama, M. Makishima, H. Miyachi, and Y. Hashimoto Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitors Bioorg. Med. Chem. Lett. 17 2007 3957 3961
54. X. Jiao, D.J. Kopecky, B. Fisher, D.E. Piper, M. Labelle, S. McKendry, M. Harrison, S. Jones, J. Jaen, A.K. Shiau, P. Escaron, J. Danao, A. Chai, P. Coward, and F. Kayser Discovery and optimization of a series of liver X receptor antagonists Bioorg. Med. Chem. Lett. 22 2012 5966 5970